Shire bags paediatric label expansion for Cinryze in the US

21st June 2018 Uncategorised 0

US regulators have approved a label expansion for Shire’s Cinryze, allowing its use in children aged six and above with hereditary angioedema.

More: Shire bags paediatric label expansion for Cinryze in the US
Source: News